These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16325417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhancement of oligodendrocyte differentiation from murine embryonic stem cells by an activator of gp130 signaling.
    Zhang P, Chebath J, Lonai P, Revel M.
    Stem Cells; 2004; 22(3):344-54. PubMed ID: 15153611
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Stimulation of myelin gene expression in vitro and of sciatic nerve remyelination by interleukin-6 receptor-interleukin-6 chimera.
    Haggiag S, Zhang PL, Slutzky G, Shinder V, Kumar A, Chebath J, Revel M.
    J Neurosci Res; 2001 Jun 15; 64(6):564-74. PubMed ID: 11398179
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells.
    Valerio A, Ferrario M, Dreano M, Garotta G, Spano P, Pizzi M.
    Mol Cell Neurosci; 2002 Dec 15; 21(4):602-15. PubMed ID: 12504593
    [Abstract] [Full Text] [Related]

  • 9. CNS myelinogenesis in vitro: myelin basic protein deficient shiverer oligodendrocytes.
    Seiwa C, Kojima-Aikawa K, Matsumoto I, Asou H.
    J Neurosci Res; 2002 Aug 01; 69(3):305-17. PubMed ID: 12125072
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
    Mothe AJ, Tator CH.
    Exp Neurol; 2008 Sep 01; 213(1):176-90. PubMed ID: 18586031
    [Abstract] [Full Text] [Related]

  • 13. Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices.
    Pizzi M, Sarnico I, Boroni F, Benarese M, Dreano M, Garotta G, Valerio A, Spano P.
    Mol Cell Neurosci; 2004 Feb 01; 25(2):301-11. PubMed ID: 15019946
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Repeated injuries dramatically affect cells of the oligodendrocyte lineage: effects of PDGF and NT-3 in vitro.
    Fressinaud C.
    Glia; 2005 Mar 01; 49(4):555-66. PubMed ID: 15578728
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.
    Selvaraju R, Bernasconi L, Losberger C, Graber P, Kadi L, Avellana-Adalid V, Picard-Riera N, Baron Van Evercooren A, Cirillo R, Kosco-Vilbois M, Feger G, Papoian R, Boschert U.
    Mol Cell Neurosci; 2004 Apr 01; 25(4):707-21. PubMed ID: 15080898
    [Abstract] [Full Text] [Related]

  • 19. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions.
    Islam MS, Tatsumi K, Okuda H, Shiosaka S, Wanaka A.
    Neurochem Int; 2009 Apr 01; 54(3-4):192-8. PubMed ID: 19070638
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.